Because lower doses and less aggressive treatment targets (for example, higher blood pressure or glycated hemoglobin) are often recommended for older adults or frailer patients, there may be dose-response relations that affected the association between drugs and mortality that we could not detect.
Some of the listed studies indicate that there may be a dose-response relationship for the number of hours in these hand positions [ 22, 35].
41 Interestingly, there may be a dose-response effect for breast feeding, with a recent case control study demonstrating a protective effect only after a duration of 3 months or more.
In both these countries, there may be a dose-response – while one or two home visits was associated with an increased likelihood that newborn care practices were applied, statistically significant associations were only seen when more than three antenatal home visits were received.
The first is that one dose may be insufficient for response if particularly strong opioids are involved in the overdose, such as unusually strong heroin or heroin adulterated with fentanyl.
To use the maximum dose of metformin in this neoadjuvant setting, as well as to ensure patient safety, the dose is gradually increased over the first few weeks of treatment, and doses may be adjusted in response to toxicities/adverse events.
In that case, the observed dose response for the average responses as a function of dose may be imagined to reflect the dose response in an individual animal (namely, the average animal), even though an individual's dose response is not directly observable in most toxicological studies.
A key concept in the field of endocrine disruption is that there may be non-traditional dose-response curves such as an inverted 'U' or even multiple 'U' shaped curves, i.e. the response is not proportional to the dose [ 42].
Quantitatively, as bland microembolization by 90Y resin microspheres has negligible biological effect [33], clinical outcomes or toxicities in both target and non-target tissue may be predicted from dose-response radiobiology quantified by 90Y PET, guiding appropriate adjuvant or mitigative action.
The use of lower doses may be associated with lower response rates, and dose escalations must be implemented to improve efficacy.
First, there may be alternative cellular responses to different MMS doses.
